These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 8075860)
21. Increase by NG-nitro-L-arginine methyl ester (L-NAME) of resistance to venous return in rats. Wang YX; Lim SL; Pang CC Br J Pharmacol; 1995 Apr; 114(7):1454-8. PubMed ID: 7541693 [TBL] [Abstract][Full Text] [Related]
22. Regional and cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats. Gardiner SM; Compton AM; Kemp PA; Bennett T Br J Pharmacol; 1990 Nov; 101(3):625-31. PubMed ID: 2076481 [TBL] [Abstract][Full Text] [Related]
23. Hemodynamic basis for the depressor activity of zaprinast, a selective cyclic GMP phosphodiesterase inhibitor. Trapani AJ; Smits GJ; McGraw DE; McMahon EG; Blaine EH J Pharmacol Exp Ther; 1991 Jul; 258(1):269-74. PubMed ID: 1649294 [TBL] [Abstract][Full Text] [Related]
24. Effects of a nitric oxide synthase inhibitor in humans with septic shock. Petros A; Lamb G; Leone A; Moncada S; Bennett D; Vallance P Cardiovasc Res; 1994 Jan; 28(1):34-9. PubMed ID: 7509259 [TBL] [Abstract][Full Text] [Related]
25. Effects of NG-nitro-L-arginine methyl ester on regional haemodynamic responses to MgSO4 in conscious rats. Kemp PA; Gardiner SM; March JE; Bennett T; Rubin PC Br J Pharmacol; 1994 Jan; 111(1):325-31. PubMed ID: 8012714 [TBL] [Abstract][Full Text] [Related]
26. The vasoconstrictor effects of L-NAME, a nitric oxide synthase inhibitor, in pregnant rabbits. Losonczy G; Mucha I; Müller V; Kriston T; Ungvári Z; Tornóci L; Rosivall L; Venuto R Br J Pharmacol; 1996 Jun; 118(4):1012-8. PubMed ID: 8799576 [TBL] [Abstract][Full Text] [Related]
27. Effect of cumulative doses of NG-nitro-L-arginine methyl ester on coronary blood flow of anesthetized and conscious dogs. Matsunaga T; Okumura K; Ishizaka H; Tsunoda R; Yasue H Arch Int Pharmacodyn Ther; 1994; 327(3):251-65. PubMed ID: 7848010 [TBL] [Abstract][Full Text] [Related]
28. Modulation of vasorelaxant responses to potassium channel openers by basal nitric oxide in the rat isolated superior mesenteric arterial bed. McCulloch AI; Randall MD Br J Pharmacol; 1996 Mar; 117(5):859-66. PubMed ID: 8851502 [TBL] [Abstract][Full Text] [Related]
29. Tonic inhibitory action by nitric oxide on spontaneous mechanical activity in rat proximal colon: involvement of cyclic GMP and apamin-sensitive K+ channels. Mulè F; D'Angelo S; Serio R Br J Pharmacol; 1999 May; 127(2):514-20. PubMed ID: 10385253 [TBL] [Abstract][Full Text] [Related]
30. Systemic nitric oxide clamping in normal humans guided by total peripheral resistance. Simonsen JA; Rasmussen MS; Johansen JB; Høilund-Carlsen PF; Bie P Acta Physiol (Oxf); 2010 Feb; 198(2):125-32. PubMed ID: 19785629 [TBL] [Abstract][Full Text] [Related]
31. Inhibition of nitric oxide synthesis improves the vasoconstrictive effect of noradrenaline in sepsis. Landín L; Lorente JA; Renes E; Cañas P; Jorge P; Liste D Chest; 1994 Jul; 106(1):250-6. PubMed ID: 8020279 [TBL] [Abstract][Full Text] [Related]
32. Pulmonary hypertension and reduced cardiac output during inhibition of nitric oxide synthesis in human septic shock. Avontuur JA; Biewenga M; Buijk SL; Kanhai KJ; Bruining HA Shock; 1998 Jun; 9(6):451-4. PubMed ID: 9645498 [TBL] [Abstract][Full Text] [Related]
33. Effects of zaprinast and rolipram on platelet aggregation and arrhythmias following myocardial ischaemia and reperfusion in anaesthetized rabbits. Holbrook M; Coker SJ Br J Pharmacol; 1991 Aug; 103(4):1973-9. PubMed ID: 1655149 [TBL] [Abstract][Full Text] [Related]
34. Pulmonary responses to selective phosphodiesterase-5 and phosphodiesterase-3 inhibitors. Matot I; Gozal Y Chest; 2004 Feb; 125(2):644-51. PubMed ID: 14769749 [TBL] [Abstract][Full Text] [Related]
35. Effects of halothane anesthesia on vasoconstrictor response to NG-nitro-L-arginine methyl ester, an inhibitor of nitric oxide synthesis, in sheep. Meyer J; Lentz CW; Herndon DN; Nelson S; Traber LD; Traber DL Anesth Analg; 1993 Dec; 77(6):1215-21. PubMed ID: 8250315 [TBL] [Abstract][Full Text] [Related]
36. Comparison of the haemodynamic profiles of elgodipine and nicardipine in the anaesthetized dog. Drieu la Rochelle CD; Grosset A; O'Connor SE Br J Pharmacol; 1994 Jan; 111(1):49-56. PubMed ID: 8012724 [TBL] [Abstract][Full Text] [Related]
37. The effect of dehydroepiandrosterone on regional blood flow in prepubertal anaesthetized pigs. Molinari C; Battaglia A; Grossini E; Mary DA; Vassanelli C; Vacca G J Physiol; 2004 May; 557(Pt 1):307-19. PubMed ID: 15034120 [TBL] [Abstract][Full Text] [Related]
38. NG-hydroxy-L-arginine prevents the haemodynamic effects of nitric oxide synthesis inhibition in the anaesthetized rat. Walder CE; Thiemermann C; Vane JR Br J Pharmacol; 1992 Oct; 107(2):476-80. PubMed ID: 1422593 [TBL] [Abstract][Full Text] [Related]
39. Cardiovascular actions of inhibitors of endothelium-derived relaxing factor (nitric oxide) formation/release in anesthetized dogs. Klabunde RE; Ritger RC; Helgren MC Eur J Pharmacol; 1991 Jun; 199(1):51-9. PubMed ID: 1893927 [TBL] [Abstract][Full Text] [Related]
40. The influence of atropine and atenolol on the cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats. Widdop RE; Gardiner SM; Kemp PA; Bennett T Br J Pharmacol; 1992 Mar; 105(3):653-6. PubMed ID: 1628153 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]